Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP2 | O95551 | 1/20 | 0.42 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.39 |
| ▸ | PDE1B | Q01064 | 8/20 | 0.38 |
| ▸ | PDE1A | P54750 | 7/20 | 0.35 |
| ▸ | PDE1C | Q14123 | 7/20 | 0.35 |
| ▸ | PDE2A | O00408 | 2/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13844408 | 0.86 | TDP2 (0.35) | TDP2PDE10AAOC3 | |
| SCHEMBL27217252 | 0.80 | TDP2 (0.38) | TDP2PDE10AAOC3PDE1BPDE1A | |
| SCHEMBL16787520 | 0.79 | PDE10A (0.32) | TDP2PDE10AAOC3 | |
| SCHEMBL21914583 | 0.71 | AOC3 (0.57) | AOC3PDE1BPDE1APDE1C | |
| SCHEMBL27217142 | 0.68 | PDE1B (0.40) | TDP2PDE10APDE1BPDE1APDE1C | |
| SCHEMBL9006723 | 0.67 | PDE1B (0.41) | TDP2PDE10AAOC3PDE1BPDE1A | |
| SCHEMBL24746024 | 0.66 | PDE2A (0.44) | TDP2PDE2A | |
| SCHEMBL27217103 | 0.66 | PDE1B (0.38) | TDP2PDE10APDE1BPDE1APDE1C | |
| SCHEMBL27217041 | 0.66 | PDE1B (0.57) | PDE1BPDE1APDE1C | |
| SCHEMBL27216987 | 0.64 | PDE1B (0.40) | TDP2PDE1BPDE1APDE1CBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3626699-B1 | SSAO INHIBITOR | SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) | 2023-07-12 | — | — | EP | disclosed |
| US-20210198220-A1 | SSAO INHIBITOR | SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) | 2021-07-01 | — | — | US | disclosed |
| US-11001563-B2 | SSAO inhibitor | SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) | 2021-05-11 | — | — | US | disclosed |
| US-20200115352-A1 | SSAO INHIBITOR | SHANDONG DANHONG PHARMACEUTICAL CO., LTD. | 2020-04-16 | — | — | US | disclosed |
| EP-3626699-A1 | SSAO INHIBITOR | Shandong Danhong Pharmaceutical Co., Ltd. (CN) | 2020-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11001563-B2 | SSAO inhibitor | SSB, ASAH2, AOX1 | TDP2 1964/4885PDE10A 1537/4885AOC3 53/4885 |
| US-20210198220-A1 | SSAO INHIBITOR | SSB, ASAH2, AOX1 | TDP2 1964/4885PDE10A 1537/4885AOC3 53/4885 |
| US-20200115352-A1 | SSAO INHIBITOR | SSB, ASAH2, AOX1 | TDP2 1964/4885PDE10A 1537/4885AOC3 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.